Published in Rev Invest Clin on December 18, 1980
Crohn's disease of the colon with takayasu's arteritis. Postgrad Med J (1982) 0.96
Drug-induced lupus syndromes. Mayo Clin Proc (1969) 3.38
Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest (1982) 3.10
Drug-induced antinuclear antibodies and lupus syndromes. Drugs (1976) 1.93
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum (2000) 1.84
Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol (1990) 1.61
Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol (1988) 1.58
The antiphospholipid/cofactor syndromes. J Rheumatol (1996) 1.57
Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol (1992) 1.56
Letter: Pre-Columbian representation of Heberden's nodes. Arthritis Rheum (1976) 1.56
Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore) (1967) 1.53
Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol (1992) 1.48
Features of Sjögren's syndrome in primary biliary cirrhosis. Ann Intern Med (1973) 1.45
Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients. J Rheumatol (1992) 1.43
Tween 20 detaches cardiolipin from ELISA plates and makes anticardiolipin antibodies undetectable regardless of the presence of beta 2-glycoprotein-I. J Immunol Methods (1994) 1.41
Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction. J Clin Invest (1980) 1.41
Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anticardiolipin antibodies of patients with primary antiphospholipid syndrome. J Rheumatol (1991) 1.40
Young immunologist's finger. J Rheumatol (1989) 1.39
Will some day PAPS fade into SLE? Lupus (1996) 1.39
Listeriosis in patients with connective tissue diseases. J Rheumatol (1994) 1.39
[Generic drugs and medical education]. Gac Med Mex (2000) 1.38
Sjögren's syndrome in progressive systemic sclerosis (scleroderma). Am J Med (1974) 1.37
Uracil-specific anti-R.N.A. antibodies in scleroderma. Lancet (1975) 1.36
Decreased circulating thymus-derived cells with receptors for the Fc portion of immunoglobulin G in systemic lupus erythematosus. J Clin Invest (1978) 1.34
Factors associated with fetal losses in severe systemic lupus erythematosus. Lupus (1996) 1.27
The range and specificity of antinuclear antibodies in systemic lupus erythematosus. Clin Exp Immunol (1970) 1.24
Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol (1990) 1.21
Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum (1978) 1.20
Articular manifestations of mixed connective tissue disease. Arthritis Rheum (1979) 1.16
Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol (1995) 1.14
Deforming arthropathy of the hands in systemic lupus erythematosus. J Rheumatol (1988) 1.12
Receptor and non-receptor-bearing lymphocytes in untreated systemic lupus erythematosus. Variations with disease activity. Rev Invest Clin (1978) 1.11
Both risk alleles for FcgammaRIIA and FcgammaRIIIA are susceptibility factors for SLE: a unifying hypothesis. Genes Immun (2004) 1.08
Heterogeneity of the spontaneously expanded and mitogen-induced generation of suppressor cell function of T cells on B cells in systemic lupus erythematosus. Arthritis Rheum (1980) 1.07
Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid. Clin Exp Immunol (1969) 1.07
Sjögren's syndrome in systemic lupus erythematosus. Clinical and subclinical manifestations. Ann Intern Med (1974) 1.07
Systemic lupus erythematosus presenting as panniculitis (lupus profundus). Ann Intern Med (1975) 1.06
Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol (1994) 1.06
Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. I. Differences in reactivity with Poly (U) and Poly-(A) Poly (U). J Immunol (1975) 1.04
Antibody penetration into living cells. I. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus. Clin Exp Immunol (1979) 1.04
Association of partial lipodystrophy and Sjögren's syndrome. Ann Intern Med (1976) 1.03
Systemic lupus erythematosus induced by therapy with interferon-beta in a patient with multiple sclerosis. Lupus (2005) 1.03
T-lymphocyte subpopulation in untreated SLE. Variations with disease activity. Arthritis Rheum (1977) 1.03
From benign polyclonal to malignant monoclonal lymphoproliferation in a patient with primary Sjögren's syndrome. Arthritis Rheum (1981) 1.00
Pleiotropy in Coffin-Lowry syndrome: sensorineural hearing deficit and premature tooth loss as early manifestations. Am J Med Genet (1993) 0.98
Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis. J Clin Lab Immunol (1981) 0.98
Autoimmune thyroid disease in primary Sjögren's syndrome. Am J Med (1995) 0.97
Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol (1995) 0.96
HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies. Ann Rheum Dis (1994) 0.96
IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 0.95
Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus. Clin Exp Immunol (1984) 0.94
Antinuclear antibodies in patients on anticonvulsant therapy. Clin Exp Immunol (1972) 0.94
Human postthymic precursor cells in health and disease. II. Their loss and dysfunction in systemic lupus erythematosus and their partial correction with serum thymic factor. J Clin Lab Immunol (1981) 0.94
Mixed connective tissue disease: some statements. Clin Rheumatol (1982) 0.94
Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial. J Rheumatol (1984) 0.93
Penetrating anti-DNA monoclonal antibodies induce activation of human peripheral blood mononuclear cells. J Autoimmun (1998) 0.92
Articular manifestations of primary Sjögren's syndrome. J Rheumatol (1983) 0.92
Australia antigen in systemic lupus. N Engl J Med (1971) 0.92
Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T gamma cells. Clin Exp Immunol (1983) 0.92
Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis. Clin Exp Immunol (2005) 0.91
Presence of hepatitis-associated antigen in systemic lupus erythematosus. Clin Exp Immunol (1972) 0.91
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups. J Autoimmun (1999) 0.90
Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases. Rheumatol Int (1984) 0.90
Cellular bases of the production of and response to interleukin-2 in man: role of autologous rosette-forming T-cell subsets defined with monoclonal antibodies. Immunology (1983) 0.90
The necrotizing vasculitides. A new pathogenetic classification. Med Clin North Am (1977) 0.90
Involvement of the urinary bladder in systemic lupus erythematosus. A pathologic study. J Rheumatol (1984) 0.89
Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction. Clin Exp Immunol (1985) 0.89
Relationship between antiphospholipid antibodies and recurrent fetal loss in patients with systemic lupus erythematosus and apparently healthy women. J Rheumatol (1989) 0.89
Interferon production by lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum (1974) 0.89
One thousand private rheumatology patients in Mexico City. Arthritis Rheum (1983) 0.88
Suppressor cell loss and dysfunction in mixed connective tissue disease. Arthritis Rheum (1980) 0.88
Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus. Scand J Immunol (2006) 0.88
Marked destructive changes occurring in osteoarthric finger joints after intra-articular injection of corticosteroids. Arthritis Rheum (1966) 0.88
Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus. Lupus (1997) 0.88
Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus. J Rheumatol (1989) 0.88
Diagnostic value of thyroid antibodies. J Clin Endocrinol Metab (1967) 0.88
Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series. Clin Exp Rheumatol (1999) 0.88
Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics (2000) 0.88
Natural killer cell activity in the systemic connective tissue diseases. J Rheumatol (1988) 0.88
Human post-thymic precursor cells in health and disease. I. Characterization of the autologous rosette-forming T cells as post-thymic precursors. Immunology (1981) 0.88
[Rheumatoid arthritis and polymyositis. Development of dermatomyositis in a patient with prolonged rheumatoid arthritis]. Rev Invest Clin (1969) 0.88
Joint contractures and scleroderma-like skin changes in the hands of insulin-dependent juvenile diabetics. J Rheumatol (1983) 0.88
Remission of systematic lupus erythematosus. Medicine (Baltimore) (1996) 0.87
Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). J Autoimmun (2007) 0.87
Letter: Treatment of scleroderma. Lancet (1974) 0.87